Tarhonska, K.; Wichtowski, M.; Wow, T.; Kołacińska-Wow, A.; Płoszka, K.; Fendler, W.; Zawlik, I.; Paszek, S.; Zuchowska, A.; Jabłońska, E.
DNA Methylation and Demethylation in Triple-Negative Breast Cancer: Associations with Clinicopathological Characteristics and the Chemotherapy Response. Biomedicines 2025, 13, 585.
https://doi.org/10.3390/biomedicines13030585
AMA Style
Tarhonska K, Wichtowski M, Wow T, Kołacińska-Wow A, Płoszka K, Fendler W, Zawlik I, Paszek S, Zuchowska A, Jabłońska E.
DNA Methylation and Demethylation in Triple-Negative Breast Cancer: Associations with Clinicopathological Characteristics and the Chemotherapy Response. Biomedicines. 2025; 13(3):585.
https://doi.org/10.3390/biomedicines13030585
Chicago/Turabian Style
Tarhonska, Kateryna, Mateusz Wichtowski, Thomas Wow, Agnieszka Kołacińska-Wow, Katarzyna Płoszka, Wojciech Fendler, Izabela Zawlik, Sylwia Paszek, Alina Zuchowska, and Ewa Jabłońska.
2025. "DNA Methylation and Demethylation in Triple-Negative Breast Cancer: Associations with Clinicopathological Characteristics and the Chemotherapy Response" Biomedicines 13, no. 3: 585.
https://doi.org/10.3390/biomedicines13030585
APA Style
Tarhonska, K., Wichtowski, M., Wow, T., Kołacińska-Wow, A., Płoszka, K., Fendler, W., Zawlik, I., Paszek, S., Zuchowska, A., & Jabłońska, E.
(2025). DNA Methylation and Demethylation in Triple-Negative Breast Cancer: Associations with Clinicopathological Characteristics and the Chemotherapy Response. Biomedicines, 13(3), 585.
https://doi.org/10.3390/biomedicines13030585
